Literature DB >> 8049438

A variant chromosome translocation at 11q13 identifying PRAD1/cyclin D1 as the BCL-1 gene.

H Komatsu1, S Iida, K Yamamoto, C Mikuni, M Nitta, T Takahashi, R Ueda, M Seto.   

Abstract

The 11q13 breakpoint region of t(11;14) (q13;q32), translocated to the Ig heavy chain locus at 14q32, has been designated as BCL-1 for B-cell leukemia/lymphoma-1, but the nature of the transcriptional unit has long remained unclear. Recently, the PRAD1 gene encoding cyclin D1, isolated from the 11q13 region, was proposed as a candidate BCL-1 gene on the basis of chromosome walking and concordant overexpression of PRAD1 mRNA in cell lines with t(11;14)(q13;q32). We report here molecular analysis of a variant translocation at the BCL-1 locus, t(11;22)(q13;q11), showing juxtaposition of the Ig light chain gene, Ig lambda, to the PRAD1 gene at its 3' end, resulting in overexpression of PRAD1 mRNA. Because only the PRAD1 gene is present between the Ig heavy chain and light chain gene breakpoints, an identity between BCL-1 and the PRAD1/cyclin D1 gene is strongly indicated.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8049438

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  14 in total

Review 1.  Multiple myeloma: increasing evidence for a multistep transformation process.

Authors:  M Hallek; P L Bergsagel; K C Anderson
Journal:  Blood       Date:  1998-01-01       Impact factor: 22.113

Review 2.  Mantle cell lymphoma--a spectrum from indolent to aggressive disease.

Authors:  Birgitta Sander; Leticia Quintanilla-Martinez; German Ott; Luc Xerri; Isinsu Kuzu; John K C Chan; Steven H Swerdlow; Elias Campo
Journal:  Virchows Arch       Date:  2015-08-23       Impact factor: 4.064

3.  Detection of cyclin D1 overexpression by real-time reverse-transcriptase-mediated quantitative polymerase chain reaction for the diagnosis of mantle cell lymphoma.

Authors:  R Suzuki; K Takemura; M Tsutsumi; S Nakamura; N Hamajima; M Seto
Journal:  Am J Pathol       Date:  2001-08       Impact factor: 4.307

4.  Cyclin D1 amplification and expression in human breast carcinoma: correlation with histological prognostic markers and oestrogen receptor expression.

Authors:  S D Worsley; B A Jennings; K H Khalil; M Mole; A C Girling
Journal:  Clin Mol Pathol       Date:  1996-02

5.  In vivo analysis of mammary and non-mammary tumorigenesis in MMTV-cyclin D1 transgenic mice deficient in p53.

Authors:  Y Hosokawa; A Papanikolaou; R D Cardiff; K Yoshimoto; M Bernstein; T C Wang; E V Schmidt; A Arnold
Journal:  Transgenic Res       Date:  2001-10       Impact factor: 2.788

Review 6.  Genomic profiles in B cell lymphoma.

Authors:  Masao Seto
Journal:  Int J Hematol       Date:  2010-08-27       Impact factor: 2.490

7.  BCL-6 and other genomic alterations in non-Hodgkin's lymphoma (NHL).

Authors:  M Butler; N Corbally; P A Dervan; D N Carney
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

8.  A rare case of t(11;22) in a mantle cell lymphoma like B-cell neoplasia resulting in a fusion of IGL and CCND1: case report.

Authors:  Cristiano Krings Rocha; Inka Praulich; Iris Gehrke; Michael Hallek; Karl-Anton Kreuzer
Journal:  Mol Cytogenet       Date:  2011-04-01       Impact factor: 2.009

Review 9.  Molecular aspects of multiple myeloma.

Authors:  G Pratt
Journal:  Mol Pathol       Date:  2002-10

10.  Truncation of 3' CCND1 by t(11;22) leads to negative SP4 CCND1 immunohistochemistry in blastoid mantle cell lymphoma.

Authors:  Fumiyo Maekawa; Chiyuki Kishimori; Miho Nakagawa; Kayo Takeoka; Katsuhiro Fukutsuka; Masahiko Hayashida; Futoshi Iioka; Masakazu Fujimoto; Kengo Takeuchi; Hirokazu Nakamine; Hitoshi Ohno
Journal:  Blood Adv       Date:  2021-01-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.